About Adaptilens
Adaptilens is a company based in Newton (United States) founded in 2018 by Liane Clamen.. Adaptilens has raised $19.1 million across 3 funding rounds from investors including Xontogeny, Massachusetts Life Sciences Center and Pillar VC. Adaptilens offers products and services including Adaptilens A-IOL. Adaptilens operates in a competitive market with competitors including TECLens, Allotex, Presbia, Visco Vision and Shanghai Conant Optical, among others.
- Headquarter Newton, United States
- Founders Liane Clamen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adaptilens, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19.1 M (USD)
in 3 rounds
-
Latest Funding Round
$17.5 M (USD), Series A
Apr 24, 2024
-
Investors
Xontogeny
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adaptilens
Adaptilens offers a comprehensive portfolio of products and services, including Adaptilens A-IOL. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Biomimetic lens that restores vision by mimicking natural eye accommodation.
Unlock access to complete
Unlock access to complete
Funding Insights of Adaptilens
Adaptilens has successfully raised a total of $19.1M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $17.5 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $17.5M
-
First Round
First Round
(12 Nov 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series A - Adaptilens | Valuation |
investors |
|
| Jun, 2021 | Amount | Grant - Adaptilens | Valuation |
investors |
|
| Nov, 2020 | Amount | Seed - Adaptilens | Valuation | Pillar VC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Adaptilens
Adaptilens has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Xontogeny, Massachusetts Life Sciences Center and Pillar VC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences innovation is supported through funding and programs.
|
Founded Year | Domain | Location | |
|
Early-stage centric tech-focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Adaptilens
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Adaptilens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adaptilens Comparisons
Competitors of Adaptilens
Adaptilens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TECLens, Allotex, Presbia, Visco Vision and Shanghai Conant Optical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Noninvasive vision correction treatments for low myopia are developed.
|
|
| domain | founded_year | HQ Location |
Corneal allografts are developed for treating presbyopia and refractive errors.
|
|
| domain | founded_year | HQ Location |
Presbyopia is addressed via the implanted Presbia Flexivue Microlens.
|
|
| domain | founded_year | HQ Location |
Silicone hydrogel-based contact lenses are supplied for vision correction.
|
|
| domain | founded_year | HQ Location |
Optical products for ophthalmic use, including specialized lenses, are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adaptilens
Frequently Asked Questions about Adaptilens
When was Adaptilens founded?
Adaptilens was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Adaptilens located?
Adaptilens is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
Who is the current CEO of Adaptilens?
Liane Clamen is the current CEO of Adaptilens. They have also founded this company.
Is Adaptilens a funded company?
Adaptilens is a funded company, having raised a total of $19.1M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.6M, raised on Nov 12, 2020.
What does Adaptilens do?
Adaptilens was founded in 2018 and is headquartered in Newton, United States. The company operates in the medical device sector, focusing on ophthalmology. Injectable intraocular lenses are developed by the firm, designed to maintain an elliptical shape within the eye. These lenses are modified by the ciliary muscles to enable clear focusing on objects. Operations center on advancing lens technology for vision correction.
Who are the top competitors of Adaptilens?
Adaptilens's top competitors include TECLens, Allotex and Shanghai Conant Optical.
What products or services does Adaptilens offer?
Adaptilens offers Adaptilens A-IOL.
Who are Adaptilens's investors?
Adaptilens has 4 investors. Key investors include Xontogeny, Massachusetts Life Sciences Center, Pillar VC, and Accanto Partners.